Ahmet Doǧan

Research interests

Publications

• Quantifying the Expanding Landscape of Clinical Actionability for Patients with Cancer

  Cancer Discovery · 2023 · 10.1158/2159-8290.cd-23-0467

• The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

  Blood · 2022 · https://doi.org/10.1182/blood.2022015851

• GPRC5D-Targeted CAR T Cells for Myeloma

  New England Journal of Medicine · 2022 · 10.1056/nejmoa2209900

• Efficacy of MEK inhibition in patients with histiocytic neoplasms

  Nature · 2019 · 10.1038/s41586-019-1012-y

• Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma

  Cancer Discovery · 2017 · 10.1158/2159-8290.cd-17-0613

• International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease

  Blood · 2017 · 10.1182/blood-2016-10-746933

• Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical setting

  Blood · 2016 · 10.1182/blood-2015-08-664649

• Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms

  Cancer Discovery · 2015 · 10.1158/2159-8290.cd-15-0913

• Left Ventricular Amyloid Deposition in Patients With Heart Failure and Preserved Ejection Fraction

  JACC Heart Failure · 2014 · 10.1016/j.jchf.2013.11.004

• Genomic and functional analysis of leukemic transformation of myeloproliferative neoplasms

  Proceedings of the National Academy of Sciences · 2014 · 10.1073/pnas.1407792111

• ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes

  Blood · 2014 · 10.1182/blood-2014-04-571091

• Renal Amyloidosis

  Clinical Journal of the American Society of Nephrology · 2013 · 10.2215/cjn.10491012

• C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up

  Kidney International · 2012 · 10.1038/ki.2012.212

• Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing

  Proceedings of the National Academy of Sciences · 2012 · https://doi.org/10.1073/pnas.1121343109

• Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing

  Blood · 2010 · 10.1182/blood-2010-08-303305

• Classification of amyloidosis by laser microdissection and mass spectrometry–based proteomic analysis in clinical biopsy specimens

  Blood · 2009 · https://doi.org/10.1182/blood-2009-07-230722

• COSMIC 2005

  British Journal of Cancer · 2006 · 10.1038/sj.bjc.6602928

• Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation

  The Lancet · 2005 · 10.1016/s0140-6736(05)66659-7

• The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website

  British Journal of Cancer · 2004 · https://doi.org/10.1038/sj.bjc.6601894

• Angioimmunoblastic T‐cell lymphoma

  British Journal of Haematology · 2003 · 10.1046/j.1365-2141.2003.04335.x

• T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication

  Gastroenterology · 2002 · 10.1053/gast.2002.33047

• Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10

  Blood · 2002 · 10.1182/blood.v99.2.627

• Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy

  The Lancet · 2001 · 10.1016/s0140-6736(00)03571-6

• CD10 and BCL-6 Expression in Paraffin Sections of Normal Lymphoid Tissue and B-Cell Lymphomas

  The American Journal of Surgical Pathology · 2000 · 10.1097/00000478-200006000-00010

• An Immunohistochemical Study

  The American Journal of Surgical Pathology · 1989 · https://doi.org/10.1097/00000478-198912000-00004

Current projects

No projects listed.